ICCC ImmuCell Corporation

USD 5.30 0.01 0.189036
Icon

ImmuCell Corporation (ICCC) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 5.30

+0.01 (+0.19)%

USD 0.04B

0.01M

N/A

N/A

Icon

ICCC

ImmuCell Corporation (USD)
COMMON STOCK | NSD
USD 5.30
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.04B

N/A

USD 5.30

ImmuCell Corporation (ICCC) Stock Forecast

N/A

Based on the ImmuCell Corporation stock forecast from 0 analysts, the average analyst target price for ImmuCell Corporation is not available over the next 12 months. ImmuCell Corporation’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of ImmuCell Corporation is Slightly Bearish, which is based on 3 positive signals and 5 negative signals. At the last closing, ImmuCell Corporation’s stock price was USD 5.30. ImmuCell Corporation’s stock price has changed by +4.13% over the past week, +1.53% over the past month and +3.72% over the last year.

No recent analyst target price found for ImmuCell Corporation
No recent average analyst rating found for ImmuCell Corporation

Company Overview ImmuCell Corporation

ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It offers First Defense, an orally delivered scours preventive product for newb...Read More

https://immucell.com

56 Evergreen Drive, Portland, ME, United States, 04103

0

December

USD

USA

Adjusted Closing Price for ImmuCell Corporation (ICCC)

Loading...

Unadjusted Closing Price for ImmuCell Corporation (ICCC)

Loading...

Share Trading Volume for ImmuCell Corporation Shares

Loading...

Compare Performance of ImmuCell Corporation Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for ICCC

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To ImmuCell Corporation (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc +0.69 (+0.17%) USD107.38B 29.93 21.06

ETFs Containing ICCC

Symbol Name ICCC's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About ImmuCell Corporation (ICCC) Stock

Stock Target Advisor's fundamental analysis for ImmuCell Corporation's stock is Slightly Bearish.

Unfortunately we do not have enough data on ICCC's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on ICCC's stock to indicate what its average analyst target is.

ICCC stock's Price/Earning ratio is 170.25. Our analysis grades ICCC stock's Price / Earning ratio at F. This means that ICCC stock's Price/Earning ratio is above 94% of the stocks in the Biotechnology sector in the NSD exchange. Based on this ICCC may be a overvalued for its sector.

The last closing price of ICCC's stock was USD 5.30.

The most recent market capitalization for ICCC is USD 0.04B.

Unfortunately we do not have enough analyst data on ICCC's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains ImmuCell Corporation's stock.

As per our most recent records ImmuCell Corporation has 0 Employees.

ImmuCell Corporation's registered address is 56 Evergreen Drive, Portland, ME, United States, 04103. You can get more information about it from ImmuCell Corporation's website at https://immucell.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...